Lingming Liang
Publications by Year
Research Areas
Advanced Breast Cancer Therapies, Acute Myeloid Leukemia Research, Regulation of Appetite and Obesity, Biochemical Analysis and Sensing Techniques, Cancer-related Molecular Pathways
Most-Cited Works
- → Identification and characterization of a melanin-concentrating hormone receptor(2001)193 cited
- → Discovery of AMG 925, a FLT3 and CDK4 Dual Kinase Inhibitor with Preferential Affinity for the Activated State of FLT3(2014)70 cited
- → Discovery of potent LPA2 (EDG4) antagonists as potential anticancer agents(2007)54 cited
- → Cancer cell-intrinsic resistance to BiTE therapy is mediated by loss of CD58 costimulation and modulation of the extrinsic apoptotic pathway(2022)36 cited
- → AMG 925 Is a Dual FLT3/CDK4 Inhibitor with the Potential to Overcome FLT3 Inhibitor Resistance in Acute Myeloid Leukemia(2014)35 cited
- → Preclinical Evaluation of AMG 925, a FLT3/CDK4 Dual Kinase Inhibitor for Treating Acute Myeloid Leukemia(2014)34 cited
- → Identification of piperazine-bisamide GHSR antagonists for the treatment of obesity(2010)26 cited
- → Discovery of a new class of ghrelin receptor antagonists(2012)23 cited
- → Discovery of a novel melanin concentrating hormone receptor 1 (MCHR1) antagonist with reduced hERG inhibition(2012)20 cited
- → Discovery and characterization of a potent and selective antagonist of melanin-concentrating hormone receptor 2(2011)18 cited